Category
Tech stack
CMS
Analytics
CDN
Framework
CRM/marketing
AI readiness
AI training policy
allowed
Terms of Service
AI-bot protection
AI files
Compliance (GEO / GDPR)
Overview
Title
Home - BioPorto US
Description
In-vitro diagnostics company introducing ProNephro AKI™ (NGAL), the first FDA-cleared test for pediatric acute kidney injury risk assessment.
Final URL
Language
en (html)
Scanned at
2026-06-30 03:56:54